US panel votes to end recommending hepatitis B vaccine for all newborns

The US panel of vaccine advisers has voted to end the recommendation for newborn vaccinations against hepatitis B, a move that has sparked debate among health officials and experts. The decision could lead to changes in the country's childhood vaccination recommendations, with calls for a review of best practices from other countries. While some argue for individual-based decision-making on vaccinating newborns, concerns about potential health risks and the spread of the virus remain prominent in the discussion.